Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Country:  U.S.A.
Treatment/Intervention:  botanical therapy
Trial Status:  Active
Results 1-19 of 19 for your search:
Start Over
Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: LP0105-1032, NCT02361216
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Germanium, NCT00651417
A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12-005, ACS IRG 58-012-49, NCT00730158
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 45 to 85
Sponsor: NCI, Other
Protocol IDs: CASE6812, NCI-2013-01372, P30CA043703, NCT01928485
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 042013-080, NCT02064673
Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE5913, NCI-2014-00266, P30CA043703, NCT02100423
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GHNSCLC-2 001, NCT02047344
Phase I Chemoprevention Trial With Green Tea Polyphenon E and Erlotinib in Patients With Premalignant Lesions of the Head and Neck
Phase: Phase I
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00014010, WCI1549-08, NCT01116336
Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing Resection
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 10-089, NCT01239095
Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 20 and over
Sponsor: Other
Protocol IDs: BCC-GI-10 Curcumin, NCT01294072
Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11043, NCI-2012-01324, 5P01CA154295-02, NCT01666756
A Prospective Evaluation of the Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors.
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: LCCC 1227, NCT01859858
Treatment of Actinic Keratoses (AK) on the Face
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GCO 14-1319, NCT02411851
Xanthohumol and Prevention of DNA Damage
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: LPI-6119, NCT02432651
Curcumin in Treating Patients With Familial Adenomatous Polyposis
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: NCI
Protocol IDs: NCI-2013-00536, CDR0000592794, NA_00011821, 00011821, R01-CA-134620, P30CA006973, NCT00641147
Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention, Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: P01 CA090890, NCT01344330
A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EH0524BlackCohosh, NCT01628536
Broccoli Sprout Extract in Treating Patients With Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: I 211911, NCI-2012-01770, K07CA148888, P30CA016056, NCT01753908
Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1404013708, NCT02178644
Start Over